Switzerland · Seed startup

Who invested in Pipra

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$250Kraised across 1 round since 2023, from 1 source

Latest round
Seed, $250KJan 2023
Investors
4
See who backed them

The rounds

  1. Jan 2023

Founders and team

From Pipra's own website: 1 founder, 2 on the team.

John KlepperCo-Founder
  • Christophe LoefflerChief Financial Officer
  • Renier BehrensSenior Software Developer

AdvisersBritta HanleyDr. Jürg WittwerPeter SchmidProf. Alasdair MacLullich

Everyone who backed them

Plug and PlayAccelerator1round
Newchip AcceleratorAccelerator1round
InnosuisseGovernment1round
EIT HealthVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Pipra as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

StartAngels NetworkAngel networkPer its own site
Forward Venture CapitalVC firmPer its own site
TR Invest AGCompanyPer its own site

Quick answers about Pipra

Who invested in Pipra?

Pipra's investors include Plug and Play, Newchip Accelerator, Innosuisse and EIT Health.

How much has Pipra raised?

Pipra has raised $250K across 1 round since 2023.

When did Pipra last raise?

Pipra's most recent round was a Seed of $250K in Jan 2023.

What was Pipra's biggest round?

Its most recent round, $250K in Jan 2023, is also its largest on record.

Who backed Pipra first?

Pipra's first round on record, in Jan 2023, was backed by Plug and Play, Newchip Accelerator and Innosuisse and 1 others.

What stage is Pipra at?

Pipra's latest named round is a Seed, in Jan 2023.

Where is Pipra based?

Pipra is based in Switzerland.

Companies like Pipra

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.